Tuesday, 31 March 2020

India News

  • Nueclear Healthcare secures $4 million from NVP

    India |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jan, 2013

    Bangalore: Nueclear Healthcare (NHL), a radiology diagnostics company aiming to provide low cost nuclear imaging services in India, has entered into a binding agreement to receive $4 milli...Read more

  • Pictor launches 5-in-1 infant testing kit in India

    India |  News | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2013

    Singapore: More than 300,000 babies die within the first 24 hours of being born in India every year, according to the latest State of the World's Mothers Report from Save The Children. An i...Read more

  • MEDIAN nominates Kapil Dhingra to its board

    India |  News | By BioSpectrum Bureau  | 0 Comment | 14 Nov, 2012

    Bangalore: MEDIAN Technologies, a leading medical imaging software solutions developer, and a service provider for image interpretation and management in oncology clinical trials, from Fran...Read more

  • Novavax, CPL Biologicals, ICGEB join hands for malaria research

    India |  News | By BioSpectrum Bureau  | 0 Comment | 20 Jul, 2012

    Bangalore: Novavax, CPL Biologicals (CPLB) and the International Centre for Genetic Engineering and Biotechnology (ICGEB), have formed a new collaboration to develop a novel malaria vaccine...Read more

  • Another Ranbaxy plant faces US FDA ire

    India |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jan, 2014

    Singapore: The year 2014 is bringing back haunting memories of the way the year gone by had started for India's biggest drug maker. While 2013 started with Ranbaxy making the largest settle...Read more

  • Biocon gets positive results in insulin glargine study

    India |  News | By BioSpectrum Bureau  | 0 Comment | 27 Jul, 2012

    Bangalore: Biocon has announced positive results from a phase I comparative study conducted in Germany of its biosimilar insulin glargine in type 1 diabetes mellitus (T1DM) patients. This ...Read more

  • GSK extends Genpact's finance contract by 5 years

    India |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jan, 2013

    Singapore: Genpact, a global leader in business process management and technology services, has been awarded a five-year contract extension by global pharmaceutical leader GlaxoSmithKline (...Read more

  • Dr. Reddy's announces management changes

    India |  News | By BioSpectrum Bureau  | 0 Comment | 28 Nov, 2012

    Hyderabad: Dr. Reddy's Laboratories announced that Mr Umang Vohra, who was the CFO of the company for the past four years, will take over the role of executive vice president and head of N...Read more

  • India to help setup pharma hub in Sri Lanka

    India |  News | By BioSpectrum Bureau  | 0 Comment | 16 Aug, 2012

    Bangalore: India is going to help Sri Lanka in setting up a proposed pharma hub, as part of its bilateral relationship with the island nation. Dr P V Appaji, director general, Pharmaceutica...Read more

  • Novartis in shock as Indian Supreme Court rules against Glivec patent case

    India |  News | By BioSpectrum Bureau  | 0 Comment | 01 Apr, 2013

    New Delhi: The Supreme Court of India has ruled against Novartis in a historic seven-year legal battle involving Novartis' chronic myeloid leukemia drug, Glivec (known in Europe as Gleevec)...Read more

  • Dr. Reddy's launches Aricept generic Donepezil

    India |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jul, 2013

    Singapore: Dr. Reddy's Laboratories has launched Donepezil Hydrochloride tablets, 23 mg, a therapeutic equivalent generic version of Aricept, 23 mg in the US market following the approval b...Read more

  • Non-invasive device to assess liver fibrosis

    India |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jul, 2012

    Singapore: In the run up to World Hepatitis Day, to be commemorated on July 28, one of the main goals globally is to raise awareness about viral hepatitis and its causes. Despite its stagge...Read more

  • Lupin gets FDA nod for Suprax oral suspension

    India |  News | By BioSpectrum Bureau  | 0 Comment | 25 Feb, 2013

    Mumbai: Lupin subsidiary, Lupin Pharmaceuticals, received approval for Suprax (Cefixime) for oral suspension, 500 mg/5mL from the US FDA. Lupin expects to commence shipping of the product ...Read more

  • BioCOS rides on established R&D protocols

    India |  Influencers | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2012

    The affordable and personalized healthcare has been a major concern worldwide. The big pharma and diagnostic companies are now realizing the strong impact of efficient computational methods...Read more

  • APAC healthcare industry becomes cloud friendly

    India |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2013

    Singapore: A recent report presented by Frost & Sullivan has said that the healthcare industry in Asia Pacific is embracing the full gamut of cloud provided services from infrastructure...Read more

  • Varian's device gets nod from Indian atomic board

    India |  News | By BioSpectrum Bureau  | 0 Comment | 30 Nov, 2012

    Singapore: US-based Varian Medical Systems has received regulatory clearance from Indian Atomic Energy Regulatory Board for the use of its TrueBeam High Intensity Mode for advanced radiosur...Read more

  • Stanford Univ, DBT India program is a big hit'

    India |  Influencers | By BioSpectrum Bureau  | 0 Comment | 26 Feb, 2013

    Dr Rajiv Doshi, executive director (US), Stanford-India Biodesign (SIB), and consulting assistant professor, Stanford University, US, was one of the many eminent individuals who attended th...Read more

  • Has collaborative commercialization arrived in India?

    India |  Opinion | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2013

    Faced with many uncertainties after the introduction of a series of reforms from the 1990s, both Indian and foreign firms have closely followed the growth of the pharmaceutical industry. Lo...Read more